Latest Articles
ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon - TipRanks
ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon TipRanks
Published: Feb. 27, 2026, 7:47 p.m.
Senjee appeals for financial help for critical medical treatment - K24 Digital
Senjee appeals for financial help for critical medical treatment K24 Digital
Published: Feb. 27, 2026, 7:31 p.m.
Senator Gallivan's Votes for the Week of February 24, 2026 - The New York State Senate (.gov)
Senator Gallivan's Votes for the Week of February 24, 2026 The New York State Senate (.gov)
Published: Feb. 27, 2026, 7:23 p.m.
'Years being dismissed': Endometriosis patient campaigns for Jess's rule in Wales - ITVX
'Years being dismissed': Endometriosis patient campaigns for Jess's rule in Wales ITVX
Published: Feb. 27, 2026, 6:51 p.m.
Pete Davidson’s girlfriend Elsie Hewitt says she has ‘inherent guilt’ for not breastfeeding their child - AOL.com
Pete Davidson’s girlfriend Elsie Hewitt says she has ‘inherent guilt’ for not breastfeeding their child AOL.com
Published: Feb. 27, 2026, 5:28 p.m.
Niger govt, NGO team up to fight uterine health issues - Peoples Gazette Nigeria
Niger govt, NGO team up to fight uterine health issues Peoples Gazette Nigeria
Published: Feb. 27, 2026, 5:23 p.m.
Pete Davidson’s girlfriend Elsie Hewitt says she has ‘inherent guilt’ for not breastfeeding their child - inkl
Pete Davidson’s girlfriend Elsie Hewitt says she has ‘inherent guilt’ for not breastfeeding their child inkl
Published: Feb. 27, 2026, 5:14 p.m.
How Endometriosis Patients Can Change The World: Cat Bohannon On Healt - Endometriosis Foundation of America
How Endometriosis Patients Can Change The World: Cat Bohannon On Healt Endometriosis Foundation of America
Published: Feb. 27, 2026, 4:54 p.m.
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer - MarketBeat
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer MarketBeat
Published: Feb. 27, 2026, 4:50 p.m.
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer - Yahoo Finance
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer Yahoo Finance
Published: Feb. 27, 2026, 4:47 p.m.
Link copied to clipboard!